![](/img/cover-not-exists.png)
238 A randomized, double-blind placebo-controlled study of NV1FGF gene therapy in critical limb ischemia patients (TAMARIS Study): Rationale, design and baseline patient characteristics
Eric Van Belle, Sigrid Nikol, Lars Norgren, Iris Baumgartner, Vickie Driver, William Hiatt, Jill BechVolume:
3
Year:
2011
Language:
english
DOI:
10.1016/s1878-6480(11)70240-3
File:
PDF, 56 KB
english, 2011